Filter posts

BIO Releases Report on Investment in Pain and Addiction Therapeutics

BIO’s Industry Analysis team has released its second report in a new series on the …

Is Your Emergency Worth It? Let’s Ask Your Insurer…

Imagine that it is 2AM and the pain is so severe that you cannot move. …

Give It a Shot – Protect Yourself from the Flu

Everyday it’s a new headline. The numbers keep rising. No, we’re not talking about the …

340B Drug Discount Program At-A-Glance

In 1992, with the support of the biopharmaceutical industry, Congress created the 340B Drug Discount …

Important South Dakota Biologics Substitution Bill Heads to Governor's Desk

One of BIO’s top priorities is passage of state laws that establish consistent standards for …

Cancer Surpasses Malaria as Top Public Health Threat in Africa

Africa is known for its diverse cultures, expansive landscapes, dramatic coastlines, luscious forests and exotic …

Drug Discount Program Strays from Patient Health to Hospital Wealth

It’s been 25 years since Congress created the 340B Drug Discount Program, a program designed …

Biotechnology in Action: How Innovation is Having an Impact in Personalized Medicine

Editor’s Note: As part of BIO’s 25th Anniversary celebration we will be spotlighting biotechnology innovations that …

Why a New Study on Drug Costs Misses the Mark

BIO President and CEO Jim Greenwood recently described 2017 as a “transformative year in medicine.” …

Combating Antimicrobial Resistance

Here’s a statistic you might not have known: an estimated 700,000 people die each year …